2023
DOI: 10.3390/ijms24043610
|View full text |Cite
|
Sign up to set email alerts
|

Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies

Abstract: Carcinoid syndrome represents a debilitating paraneoplastic disease, caused by the secretion of several substances, occurring in about 10–40% of patients with well-differentiated neuroendocrine tumors (NETs). The main signs and symptoms associated with carcinoid syndrome are flushing, diarrhea, hypotension, tachycardia, bronchoconstriction, venous telangiectasia, dyspnea and fibrotic complications (mesenteric and retroperitoneal fibrosis, and carcinoid heart disease). Although there are several drugs available… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 129 publications
(144 reference statements)
0
2
0
Order By: Relevance
“…In addition to symptoms caused by primary intraspinal tumors, symptoms of carcinoid syndrome may also occur, such as facial flushing, nausea, vomiting, diarrhea, asthma, cardiac symptoms, blood pressure fluctuations, and pigmentation. [9] The patient had no symptoms of carcinoid syndrome except numbness and pain in the extremities.…”
Section: Discussionmentioning
confidence: 92%
“…In addition to symptoms caused by primary intraspinal tumors, symptoms of carcinoid syndrome may also occur, such as facial flushing, nausea, vomiting, diarrhea, asthma, cardiac symptoms, blood pressure fluctuations, and pigmentation. [9] The patient had no symptoms of carcinoid syndrome except numbness and pain in the extremities.…”
Section: Discussionmentioning
confidence: 92%
“…Carcinoid syndrome (CS) refers to a series of symptoms mediated by various biologically active substances secreted by neuroendocrine tumors (NETs), which mainly located in the gastrointestinal tract and lungs. The two most common manifestations of this syndrome are diarrhea and facial flushing (Vitale, et al, 2023). While some researchers have uncovered that the release of active substances such as serotonin (5-hydroxytryptamine, 5-HT), histamine, kinins, prostaglandins, and tachykinins was a significant factor in causing CS, the mechanisms behind the occurrence of CS remain unclear (Gade et al, 2020).…”
Section: Introductionmentioning
confidence: 99%